Kelsey E. Larson

Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer

Priyanka Sharma, Shane R. Stecklein, Rachel Yoder et al. · JAMA Oncology · 2023 · 164 citations · Full text

Medicine, Oncology, Pharmacology +17

Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I–III Triple-negative Breast Cancer (NeoSTOP)

Priyanka Sharma, Bruce F. Kimler, Anne O’Dea et al. · Clinical Cancer Research · 2020 · 109 citations · Full text

Medicine, Oncology, Pharmacology +17

Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions

Lyndsey J. Kilgore, Sabrina S. Korentager, Amanda N. Hangge et al. · Annals of Surgical Oncology · 2018 · 81 citations

Medicine, Biomedical Engineering, Oncology +13

Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries

James Glasbey, Tom Abbott, Adesoji Ademuyiwa et al. · The Lancet · 2022 · 75 citations · Full text

Nursing, Health Systems, Surgery +15

Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ

E. Shelley Hwang, Terry Hyslop, Thomas Lynch et al. · JAMA · 2024 · 69 citations · Full text

Medicine, Oncology, Surgery +17